These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 23547262)
1. Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling. Siddique MM; Li Y; Wang L; Ching J; Mal M; Ilkayeva O; Wu YJ; Bay BH; Summers SA Mol Cell Biol; 2013 Jun; 33(11):2353-69. PubMed ID: 23547262 [TBL] [Abstract][Full Text] [Related]
2. Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro. Siddique MM; Bikman BT; Wang L; Ying L; Reinhardt E; Shui G; Wenk MR; Summers SA PLoS One; 2012; 7(9):e44042. PubMed ID: 22984457 [TBL] [Abstract][Full Text] [Related]
3. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Chaurasia B; Tippetts TS; Mayoral Monibas R; Liu J; Li Y; Wang L; Wilkerson JL; Sweeney CR; Pereira RF; Sumida DH; Maschek JA; Cox JE; Kaddai V; Lancaster GI; Siddique MM; Poss A; Pearson M; Satapati S; Zhou H; McLaren DG; Previs SF; Chen Y; Qian Y; Petrov A; Wu M; Shen X; Yao J; Nunes CN; Howard AD; Wang L; Erion MD; Rutter J; Holland WL; Kelley DE; Summers SA Science; 2019 Jul; 365(6451):386-392. PubMed ID: 31273070 [TBL] [Abstract][Full Text] [Related]
4. Myristic acid increases dihydroceramide Δ4-desaturase 1 (DES1) activity in cultured rat hepatocytes. Ezanno H; le Bloc'h J; Beauchamp E; Lagadic-Gossmann D; Legrand P; Rioux V Lipids; 2012 Feb; 47(2):117-28. PubMed ID: 22139871 [TBL] [Abstract][Full Text] [Related]
5. N-Myristoylation targets dihydroceramide Delta4-desaturase 1 to mitochondria: partial involvement in the apoptotic effect of myristic acid. Beauchamp E; Tekpli X; Marteil G; Lagadic-Gossmann D; Legrand P; Rioux V Biochimie; 2009; 91(11-12):1411-9. PubMed ID: 19647031 [TBL] [Abstract][Full Text] [Related]
6. Myristic acid increases the activity of dihydroceramide Delta4-desaturase 1 through its N-terminal myristoylation. Beauchamp E; Goenaga D; Le Bloc'h J; Catheline D; Legrand P; Rioux V Biochimie; 2007 Dec; 89(12):1553-61. PubMed ID: 17716801 [TBL] [Abstract][Full Text] [Related]
7. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena. Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621 [TBL] [Abstract][Full Text] [Related]
8. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes. Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011 [TBL] [Abstract][Full Text] [Related]
9. Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms. Casasampere M; Ordóñez YF; Casas J; Fabrias G Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):264-275. PubMed ID: 27894925 [TBL] [Abstract][Full Text] [Related]
10. Targeting dihydroceramide desaturase 1 (Des1): Syntheses of ceramide analogues with a rigid scaffold, inhibitory assays, and AlphaFold2-assisted structural insights reveal cyclopropenone PR280 as a potent inhibitor. Rivero P; Ivanova V; Barril X; Casampere M; Casas J; Fabriàs G; Díaz Y; Matheu MI Bioorg Chem; 2024 Apr; 145():107233. PubMed ID: 38422591 [TBL] [Abstract][Full Text] [Related]
11. Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology. Casasampere M; Ordoñez YF; Pou A; Casas J Chem Phys Lipids; 2016 May; 197():33-44. PubMed ID: 26248324 [TBL] [Abstract][Full Text] [Related]
12. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis. Stiban J; Perera M Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172 [TBL] [Abstract][Full Text] [Related]
13. Dihydroceramide-desaturase-1-mediated caspase 9 activation through ceramide plays a pivotal role in palmitic acid-induced HepG2 cell apoptosis. Zhu Q; Yang J; Zhu R; Jiang X; Li W; He S; Jin J Apoptosis; 2016 Sep; 21(9):1033-44. PubMed ID: 27364952 [TBL] [Abstract][Full Text] [Related]
14. Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition. Savira F; Magaye R; Scullino CV; Flynn BL; Pitson SM; Anderson D; Creek DJ; Hua Y; Xiong X; Huang L; Liew D; Reid C; Kaye D; Kompa AR; Wang BH Toxicol Lett; 2021 Oct; 350():133-142. PubMed ID: 34303789 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance. Hu W; Ross J; Geng T; Brice SE; Cowart LA J Biol Chem; 2011 May; 286(19):16596-605. PubMed ID: 21454530 [TBL] [Abstract][Full Text] [Related]